These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The biochemistry of the cancer cell. Purine and pyrimidine metabolism]. Pillwein K; Jayaram HN; Wever G Padiatr Padol; 1986; 21(4):323-34. PubMed ID: 3562043 [No Abstract] [Full Text] [Related]
3. Chemotherapy of solid tumors. Alberto P Aktuelle Probl Chir; 1970; 14():807-34. PubMed ID: 4147168 [No Abstract] [Full Text] [Related]
4. The need for additional alkylating agents and antimetabolites. Heidelberger C Cancer Res; 1969 Dec; 29(12):2435-42. PubMed ID: 4905240 [No Abstract] [Full Text] [Related]
5. [Influencing the immune status of cancer patients through chemotherapy]. Micksche M Wien Med Wochenschr; 1975 Dec; 125(50-52):729-35. PubMed ID: 779283 [No Abstract] [Full Text] [Related]
6. [Chemotherapy of malignant tumors. 44]. Seidenglanz G Pharm Prax; 1970; 6():122-38. PubMed ID: 4917035 [No Abstract] [Full Text] [Related]
7. [Derivatives of pyrimidine and purine as antimetabolites in the metabolism of plasmodia (Plasmodium vinckei) (author's transl)]. Heischkeil R Tropenmed Parasitol; 1974 Mar; 25(1):105-15. PubMed ID: 4839006 [No Abstract] [Full Text] [Related]
8. Antagonists of purine and pyrimidine metabolites and of folic acid. TIMMIS GM Adv Cancer Res; 1961; 6():369-401. PubMed ID: 13921293 [No Abstract] [Full Text] [Related]
10. Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer. Parker WB Chem Rev; 2009 Jul; 109(7):2880-93. PubMed ID: 19476376 [No Abstract] [Full Text] [Related]
11. The present approach to systematic cancer therapy. Mukerjea DN; Koven BJ Indian J Cancer; 1970 Sep; 7(3):174-90. PubMed ID: 4927710 [No Abstract] [Full Text] [Related]
13. Chemotherapy and comparative biochemistry: G. H. A. Clowes memorial lecture. Hitchings GH Cancer Res; 1969 Nov; 29(11):1895-903. PubMed ID: 4982548 [No Abstract] [Full Text] [Related]
14. Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules. Allison AC; Kowalski WJ; Muller CJ; Waters RV; Eugui EM Transplant Proc; 1993 Jun; 25(3 Suppl 2):67-70. PubMed ID: 8516949 [No Abstract] [Full Text] [Related]
15. An isocratic, reversed-phase HPLC method for the determination of postischemic efflux of purines and pyrimidines during reperfusion of isolated liver. Toshchakov VY; Bashkina LV; Onishchenko NA; Shumakov VI Biochemistry (Mosc); 1998 Feb; 63(2):219-23. PubMed ID: 9526118 [TBL] [Abstract][Full Text] [Related]
16. Advances in purine and pyrimidine metabolism in health and diseases. Hirano M; Peters GJ Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):495-501. PubMed ID: 27906626 [TBL] [Abstract][Full Text] [Related]
17. Immunosuppression and chemotherapeutic agents. Kim Z Ann Allergy; 1981 Aug; 47(2):79-83. PubMed ID: 7258742 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of purine and pyrimidine compounds by vibrios. AGARWALA SC; MURTI CR; SHRIVASTAVA DL Enzymologia; 1954 Mar; 16(5):322-8. PubMed ID: 13200479 [No Abstract] [Full Text] [Related]
19. [Urinary elimination of purine and pyrimidine under the therapeutic influence of aspartic acid in chronic hepatitis]. Iencica R; Suciu A Stud Cercet Med Interna; 1972; 13(1):63-70. PubMed ID: 5022327 [No Abstract] [Full Text] [Related]
20. Inhibitors of de novo purine and pyrimidine synthesis as immunosuppressive drugs. Allison AC; Eugui EM Transplant Proc; 1993 Jun; 25(3 Suppl 2):8-18. PubMed ID: 8516951 [No Abstract] [Full Text] [Related] [Next] [New Search]